Medical Termination of Pregnancy (MTP) Drugs Used in India
In India, the standard drugs used for medical termination of pregnancy are mifepristone (200 mg) followed by misoprostol (400-800 mcg), with mifepristone approved for use up to 9 weeks of gestation 1.
Primary Regimen
The combination of mifepristone and misoprostol is the most effective regimen for medication abortion, with significantly better outcomes than misoprostol alone 2. This combination has been successfully used in India since mifepristone's introduction in 2002 1, 3.
Recommended Dosing Protocol
- Mifepristone: 200 mg orally (as effective as 600 mg) 2
- Followed by Misoprostol: 400-800 mcg, administered 36-48 hours after mifepristone 2, 3
- Route: Misoprostol can be given orally, vaginally, sublingually, or buccally
Critical caveat: Concurrent administration (both drugs at the same time) is significantly less effective (68.8% vs 84.3% success rate) and should NOT be used 4. The 48-hour interval between medications is essential for optimal efficacy.
Alternative Regimen: Misoprostol-Only
When mifepristone is unavailable, misoprostol-only regimens can be used, though they are less effective 2:
- Dose: 400-600 mcg every 4-6 hours
- Effectiveness: Higher ongoing pregnancy rates (32% at 24 hours vs 4% with combination) 2
- Abortion time: Longer (11-12 hours vs 5.8-8 hours with combination) 2
Other Medications Studied in India
Methotrexate with misoprostol has been studied as an alternative in India, showing 90% success rate for pregnancies up to 8 weeks 5. However, this is not the standard regimen and is less commonly used than mifepristone-misoprostol.
Critical Public Health Context in India
Major safety concern: Despite requiring a prescription, 90% of MTP pills in India are obtained directly from pharmacies without medical supervision 6. A concerning 97.3% of women using unsupervised MTP pills are unaware of potential complications, and 84% do not follow recommended regimens 6.
Common Complications from Unsupervised Use
Studies from Indian tertiary centers show that women presenting after self-administered MTP pills most commonly experience 7:
- Incomplete abortion (71.1% of cases)
- Shock (13.2%)
- Sepsis (10.5%)
- Serious outcomes including maternal deaths, ICU admissions, and prolonged hospitalizations
Availability Issues
A 2023 mystery client study in Mumbai found that medication abortion pills were in stock in only 11% of pharmacies visited, despite being legally available 1. Pharmacy workers frequently cited overregulation and cumbersome stocking requirements as barriers, with 23% incorrectly stating the pills were banned or illegal 1.
Clinical Implications
For healthcare providers in India: The standard evidence-based regimen remains mifepristone 200 mg followed 36-48 hours later by misoprostol 400-800 mcg. However, the widespread unsupervised use and limited pharmacy availability create a dangerous gap between recommended practice and real-world access, necessitating improved patient education about proper regimens and potential complications.